Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer.
Rieko KaneharaAtsushi GotoTomone WatanabeKosuke InoueMasataka TaguriSatoshi KobayashiKenjiro ImaiEiko SaitoKota KatanodaMotoki IwasakiKen OhashiMitsuhiko NodaTakahiro HigashiPublished in: Journal of diabetes investigation (2022)
We observed that patients with stage III CRC and diabetes are less likely to receive adjuvant chemotherapy than those without diabetes, and postoperative complications might partially account for the association.